Works matching DE "PHOSPHOLEMMAN"

Results: 14

Purinergic activation of rat skeletal muscle membranes increases V and Na affinity of the Na,K-ATPase and phosphorylates phospholemman and α1 subunits.

Published in:

Pflügers Archiv: European Journal of Physiology, 2012, v. 463, n. 2, p. 319, doi. 10.1007/s00424-011-1050-2

By:

Walas, Helle;
Juel, Carsten

Publication type:

Article

FXYD8, a Novel Regulator of Renal Na+/K+-ATPase in the Euryhaline Teleost, Tetraodon nigroviridis.

Published in:

Frontiers in Physiology, 2017, p. 1, doi. 10.3389/fphys.2017.00576

By:

Pei-Jen Wang;
Wen-Kai Yang;
Chia-Hao Lin;
Hau-Hsuan Hwang;
Tsung-Han Lee

Publication type:

Article

Fibre type-specific change in FXYD1 phosphorylation during acute intense exercise in humans.

Published in:

Journal of Physiology, 2013, v. 591, n. 6, p. 1523, doi. 10.1113/jphysiol.2012.247312

By:

Thomassen, Martin;
Murphy, Robyn M.;
Bangsbo, Jens

Publication type:

Article

Phospholemman Deficiency in Postinfarct Hearts: Enhanced Contractility but Increased Mortality.

Published in:

CTS: Clinical & Translational Science, 2012, v. 5, n. 3, p. 235, doi. 10.1111/j.1752-8062.2012.00403.x

By:

Mirza, M. Ayoub;
Lane, Susan;
Yang, Zequan;
Karaoli, Themis;
Akosah, Kwame;
Hossack, John;
McDuffie, Marcia;
Wang, JuFang;
Zhang, Xue-Qian;
Song, Jianliang;
Cheung, Joseph Y.;
Tucker, Amy L.

Publication type:

Article

FXYD6 is a new biomarker of cholangiocarcinoma.

Published in:

Oncology Letters, 2014, v. 7, n. 2, p. 393, doi. 10.3892/ol.2013.1727

By:

XIONGFEI CHEN;
MINGZHU SUN;
YAZHUO HU;
HONGHONG ZHANG;
ZHANBO WANG;
NINGXIN ZHOU;
XINYUN YAN

Publication type:

Article

Phospholemman, a major regulator of skeletal muscle Na+/K+-ATPase, is not mutated in probands with hypokalemic periodic paralysis.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 14, n. 4, p. 3229, doi. 10.3892/etm.2017.4848

By:

YING-YING CHEN;
XIAO-YING WANG;
QIU-XIA FU;
YI KANG;
HE-BIN YAO

Publication type:

Article

Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman.

Published in:

Cardiovascular Research, 2014, v. 104, n. 1, p. 72, doi. 10.1093/cvr/cvu182

By:

Boguslavskyi, Andrii;
Pavlovic, Davor;
Aughton, Karen;
Clark, James E.;
Howie, Jacqueline;
Fuller, William;
Shattock, Michael J.

Publication type:

Article

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.

Published in:

PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0188006

By:

Arystarkhova, Elena;
Bouley, Richard;
Liu, Yi Bessie;
Sweadner, Kathleen J.

Publication type:

Article

Regulation of the cardiac Na+ pump by palmitoylation of its catalytic and regulatory subunits.

Published in:

Biochemical Society Transactions, 2013, v. 41, n. 1, p. 95, doi. 10.1042/BST20120269

By:

Howie, Jacqueline;
Tulloch, Lindsay B.;
Shattock, Michael J.;
Fuller, William

Publication type:

Article

Regulation of the cardiac sodium pump.

Published in:

Cellular & Molecular Life Sciences, 2013, v. 70, n. 8, p. 1357, doi. 10.1007/s00018-012-1134-y

By:

Fuller, W.;
Tulloch, L.;
Shattock, M.;
Calaghan, S.;
Howie, J.;
Wypijewski, K.

Publication type:

Article

Surface Charges of the Membrane Crucially Affect Regulation of Na,K-ATPase by Phospholemman (FXYD1)

Published in:

Journal of Membrane Biology, 2013, v. 246, n. 12, p. 967, doi. 10.1007/s00232-013-9600-5

By:

Cirri, Erica;
Kirchner, Corinna;
Becker, Simon;
Katz, Adriana;
Karlish, Steven J.;
Apell, Hans-Jürgen

Publication type:

Article

Chronic Nicotine Modifies Skeletal Muscle Na,K-ATPase Activity through Its Interaction with the Nicotinic Acetylcholine Receptor and Phospholemman.

Published in:

PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033719

By:

Chibalin, Alexander V.;
Heiny, Judith A.;
Benziane, Boubacar;
Prokofiev, Alexander V.;
Vasiliev, Alexander V.;
Kravtsova, Violetta V.;
Krivoi, Igor I.

Publication type:

Article

Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase.

Published in:

Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-01145-3

By:

Plain, Fiona;
Howie, Jacqueline;
Kennedy, Jennifer;
Brown, Elaine;
Shattock, Michael J.;
Fraser, Niall J.;
Fuller, William

Publication type:

Article

Development of a high-affinity peptide that prevents phospholemman (PLM) inhibition of the sodium/calcium exchanger 1 (NCX1).

Published in:

Biochemical Journal, 2016, v. 473, n. 15, p. 2413, doi. 10.1042/BCJ20160465

By:

Wanichawan, Pimthanya;
Hodne, Kjetil;
Hafver, Tandekile Lubelwana;
Lunde, Marianne;
Martinsen, Marita;
Louch, William Edward;
Sejersted, Ole Mathias;
Carlson, Cathrine Rein

Publication type:

Article

Works matching DE "PHOSPHOLEMMAN"

Purinergic activation of rat skeletal muscle membranes increases V and Na affinity of the Na,K-ATPase and phosphorylates phospholemman and α1 subunits.

FXYD8, a Novel Regulator of Renal Na<sup>+</sup>/K<sup>+</sup>-ATPase in the Euryhaline Teleost, Tetraodon nigroviridis.

Fibre type-specific change in FXYD1 phosphorylation during acute intense exercise in humans.

Phospholemman Deficiency in Postinfarct Hearts: Enhanced Contractility but Increased Mortality.

FXYD6 is a new biomarker of cholangiocarcinoma.

Phospholemman, a major regulator of skeletal muscle Na<sup>+</sup>/K<sup>+</sup>-ATPase, is not mutated in probands with hypokalemic periodic paralysis.

Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman.

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.

Regulation of the cardiac Na<sup>+</sup> pump by palmitoylation of its catalytic and regulatory subunits.

Regulation of the cardiac sodium pump.

Surface Charges of the Membrane Crucially Affect Regulation of Na,K-ATPase by Phospholemman (FXYD1)

Chronic Nicotine Modifies Skeletal Muscle Na,K-ATPase Activity through Its Interaction with the Nicotinic Acetylcholine Receptor and Phospholemman.

Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase.

Development of a high-affinity peptide that prevents phospholemman (PLM) inhibition of the sodium/calcium exchanger 1 (NCX1).